The Impact of Cardiac Injury on COVID-19 Patients Mortality: A Systematic Review and Meta-Analysis

Nisa Amnifolia Niazta, Hiradipta Ardining, Muchammad Dzikrul haq Karimullah

Abstract


Background: Cardiovascular system was the second most common organ system affected by COVID-19. Cardiac injury has been reported in many COVID-19 cases. The purpose of this study was to investigate the correlation between cardiac injury with mortality in COVID-19 patients.

Methods: We performed a systematic review and meta-analysis study. The relevant studies were identified through scientific electronic databases such as PubMed, Cochrane, and ScienceDirect up to August 2020. The study quality assessment was conducted using the GRADE approach. The pooled odds ratio (OR) and 95% confidence interval (CI) were estimated using the random-effects model.  

Results: A total of 10 studies involving 2619 patients were included in the meta-analysis. The incidence of cardiac injury in COVID-19 patients was 28.5%. The all-cause mortality was significantly higher in patients with cardiac injury (52.8% vs. 13.1%; OR = 13.78; 95% CI = 7.22-26.32; I 2 = 88%; Z= 7.95; P < 0.00001).

Conclusion: Cardiac injury is associated with higher mortality in COVID-19 patients. The cardiac injury should be considered as an important variable in the risk stratification for mortality in COVID-19. 


Keywords


cardiac injury, troponin, mortality, COVID-19

Full Text:

PDF

References


World Health Organization. Coronavirus Disease (COVID-19) Weekly Epidemiological Update. Journal of Cardiovascular Nursing. 2020.

Gugus Tugas Percepatan Penanganan COVID-19. Peta Sebaran | Gugus Tugas Percepatan Penanganan COVID-19. Covid19.Go.Id. 2020.

Center for Strategic & International STudies. Southeast Asia Covid-19 Tracker | Center for Strategic and International Studies. Https://Www.Csis.Org. 2020.

Henry BM, Oliveira MHS, Benoit S, Plebani M. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and morality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;58(7):1021–8.

Akhmerov A, Marbán E. COVID-19 and the Heart. Circ Res. 2020;126(10):1443–55.

Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol. 2020;31(5):1003–8.

Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020;17(9):543–58.

Schünemann H, Brozek J, Guyatt G, Oxman A. GRADE Handbook. 2013;(October):1–103.

Review Manager (RevMan) [Computer program]. Version 5.4. The Cochrane Collaboration. 2020.

Atri D, Siddiqi HK, Lang JP, Nauffal V, Morrow DA, Bohula EA. COVID-19 for the Cardiologist: Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies. JACC Basic to Transl Sci. 2020;5(5):518–36.

Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr Clin Res Rev. 2020;14(3):247–50.

XH Y, Li T, He Z. A pathological report of Three COVID-19 cases by minimal invasive autopsies. PubMed. 2008;345–9.

Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–7.

Kang Y, Chen T, Mui D, Ferrari V, Jagasia D, Scherrer-Crosbie M, et al. Cardiovascular manifestations and treatment considerations in COVID-19. Heart. 2020;106(15):1132–41.

Wang Y, Wang Z, Tse G, Zhang L, Wan EY, Guo Y, et al. Cardiac arrhythmias in patients with COVID-19. J Arrhythmia. 2020;(June):1–10.

Schiavone M, Gobbi C, Zoccai GB, D'Ascenzo F, Palazzuoli A, Gasperetti A, et al. Acute Coronary Syndrome and Covid-19: Exploring the Uncertainties. J Clin Med. 2020;9(6): 1683.




DOI: https://doi.org/10.21776/ub.hsj.2020.001.04.05

Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Nisa Amnifolia Niazta

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.